Zobrazeno 1 - 10
of 4 135
pro vyhledávání: '"Poulain, L."'
Autor:
Bourafai-Aziez A, Benabderrahmane M, Paysant H, Weiswald LB, Poulain L, Carlier L, Ravault D, Jouanne M, Coadou G, Oulyadi H, Voisin-Chiret AS, Sopková-de Oliveira Santos J, Sebban M
Publikováno v:
Drug Design, Development and Therapy, Vol Volume 15, Pp 5035-5059 (2021)
Asma Bourafai-Aziez,1 Mohammed Benabderrahmane,2 Hippolyte Paysant,3,4 Louis-Bastien Weiswald,3,4 Laurent Poulain,3,4 Ludovic Carlier,5 Delphine Ravault,5 Marie Jouanne,2 Gaël Coadou,1 Hassan Oulyadi,1 Anne-Sophie Voisin-Chiret,2 Jana Sopková-de Ol
Externí odkaz:
https://doaj.org/article/1e0169606ae444dbb4a8160f229da0f6
Autor:
Bressi, M., Cavalli, F., Putaud, J.P., Fröhlich, R., Petit, J.-E., Aas, W., Äijälä, M., Alastuey, A., Allan, J.D., Aurela, M., Berico, M., Bougiatioti, A., Bukowiecki, N., Canonaco, F., Crenn, V., Dusanter, S., Ehn, M., Elsasser, M., Flentje, H., Graf, P., Green, D.C., Heikkinen, L., Hermann, H., Holzinger, R., Hueglin, C., Keernik, H., Kiendler-Scharr, A., Kubelová, L., Lunder, C., Maasikmets, M., Makeš, O., Malaguti, A., Mihalopoulos, N., Nicolas, J.B., O'Dowd, C., Ovadnevaite, J., Petralia, E., Poulain, L., Priestman, M., Riffault, V., Ripoll, A., Schlag, P., Schwarz, J., Sciare, J., Slowik, J., Sosedova, Y., Stavroulas, I., Teinemaa, E., Via, M., Vodička, P., Williams, P.I., Wiedensohler, A., Young, D.E., Zhang, S., Favez, O., Minguillón, M.C., Prevot, A.S.H.
Publikováno v:
In Atmospheric Environment: X April 2021 10
Autor:
Caquelin L; Univ Rennes, CHU Rennes, Inserm, Centre d'investigation clinique de Rennes (CIC1414), Service de Pharmacologie Clinique, Institut de Recherche en Santé, Environnement et Travail (Irset), UMR S 1085, EHESP, Rennes, France., Badra P; Univ Rennes, CHU Rennes, Inserm, Centre d'investigation clinique de Rennes (CIC1414), Service de Pharmacologie Clinique, Institut de Recherche en Santé, Environnement et Travail (Irset), UMR S 1085, EHESP, Rennes, France.; ReCAP/F-CRIN, INSERM, Paris, France., Poulain L; Univ Rennes, CHU Rennes, Inserm, Centre d'investigation clinique de Rennes (CIC1414), Service de Pharmacologie Clinique, Institut de Recherche en Santé, Environnement et Travail (Irset), UMR S 1085, EHESP, Rennes, France., Laviolle B; Univ Rennes, CHU Rennes, Inserm, Centre d'investigation clinique de Rennes (CIC1414), Service de Pharmacologie Clinique, Institut de Recherche en Santé, Environnement et Travail (Irset), UMR S 1085, EHESP, Rennes, France., Ursino M; ReCAP/F-CRIN, INSERM, Paris, France.; Unit of Clinical Epidemiology, Assistance Publique-Hôpitaux de Paris, CHU Robert Debré, Inserm CIC-EC 1426, Paris, France.; Inserm, Centre de Recherche des Cordeliers, Université Paris Cité, Sorbonne Université, Paris, France.; Inria Paris, Paris, France., Locher C; Univ Rennes, CHU Rennes, Inserm, Centre d'investigation clinique de Rennes (CIC1414), Service de Pharmacologie Clinique, Institut de Recherche en Santé, Environnement et Travail (Irset), UMR S 1085, EHESP, Rennes, France.; ReCAP/F-CRIN, INSERM, Paris, France.
Publikováno v:
Research synthesis methods [Res Synth Methods] 2024 Nov; Vol. 15 (6), pp. 964-977. Date of Electronic Publication: 2024 Aug 05.
Autor:
Neviere Z; Department of Medical Oncology, Comprehensive Cancer Centre F. Baclesse, UNICANCER, Caen, France., Blanc-Fournier C; Department of Bio-Pathology, Comprehensive Cancer Centre F. Baclesse, UNICANCER, Caen, France., Guizard AV; Calvados General Tumour Registry, Cancers & Préventions - U1086 Inserm, Centre François Baclesse, Caen, France., Elie N; Federative Structure 4207 'Normandie Oncologie', PLATON Services Unit, VIRTUAL'HIS, Université de Caen Normandie, Caen, France., Giffard F; Federative Structure 4207 'Normandie Oncologie', PLATON Services Unit, VIRTUAL'HIS, Université de Caen Normandie, Caen, France.; Interdisciplinary Research Unit for Cancer Prevention and Treatment, Federative Structure 4207 'Normandie Oncologie', F. Baclesse, Université of Caen Normandie, Inserm U1086 ANTICIPE, Caen, France., Lequesne J; Biostatistics Department, Comprehensive Cancer Centre François Baclesse, UNICANCER, Caen, France., Emile G; Department of Medical Oncology, Comprehensive Cancer Centre F. Baclesse, UNICANCER, Caen, France., Poulain L; Interdisciplinary Research Unit for Cancer Prevention and Treatment, Federative Structure 4207 'Normandie Oncologie', F. Baclesse, Université of Caen Normandie, Inserm U1086 ANTICIPE, Caen, France., Lasnon C; Interdisciplinary Research Unit for Cancer Prevention and Treatment, Federative Structure 4207 'Normandie Oncologie', F. Baclesse, Université of Caen Normandie, Inserm U1086 ANTICIPE, Caen, France. c.lasnon@baclesse.unicancer.fr.; Nuclear Medicine Department, Comprehensive Cancer Centre François Baclesse, UNICANCER, 3 Avenue du General Harris, BP 45026, Caen, 14076, France. c.lasnon@baclesse.unicancer.fr.
Publikováno v:
BMC cancer [BMC Cancer] 2024 Oct 29; Vol. 24 (1), pp. 1328. Date of Electronic Publication: 2024 Oct 29.
Autor:
Groo, A.C., Hedir, S., Since, M., Brotin, E., Weiswald, L.-B., Paysant, H., Nee, G., Coolzaet, M., Goux, D., Delépée, R., Freret, T., Poulain, L., Voisin-Chiret, A.S., Malzert-Fréon, A.
Publikováno v:
In International Journal of Pharmaceutics 25 September 2020 587
Autor:
Thorel L; INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), Université de Caen Normandie, Caen, France.; Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France., Perréard M; INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), Université de Caen Normandie, Caen, France.; Department of Head and Neck Surgery, Caen University Hospital, Caen, France., Florent R; ORGAPRED core facility, US PLATON, Université de Caen Normandie, Caen, France., Divoux J; INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), Université de Caen Normandie, Caen, France.; Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France.; ORGAPRED core facility, US PLATON, Université de Caen Normandie, Caen, France., Coffy S; Biomics, CEA, Inserm, IRIG, UA13 BGE, Univ. Grenoble Alpes, Grenoble, France., Vincent A; CNRS UMR9020, INSERM U1277, CANTHER Cancer Heterogeneity Plasticity and Resistance to Therapies, Univ. Lille, CNRS, Inserm, CHU Lille, Lille, France., Gaggioli C; CNRS UMR7284, INSERM U1081, Institute for Research on Cancer and Aging, Nice (IRCAN), 3D-Hub-S Facility, CNRS University Côte d'Azur, Nice, France., Guasch G; CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Epithelial Stem Cells and Cancer Team, Aix-Marseille University, Marseille, France., Gidrol X; Biomics, CEA, Inserm, IRIG, UA13 BGE, Univ. Grenoble Alpes, Grenoble, France., Weiswald LB; INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), Université de Caen Normandie, Caen, France. lb.weiswald@baclesse.unicancer.fr.; Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France. lb.weiswald@baclesse.unicancer.fr.; ORGAPRED core facility, US PLATON, Université de Caen Normandie, Caen, France. lb.weiswald@baclesse.unicancer.fr., Poulain L; INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), Université de Caen Normandie, Caen, France. l.poulain@baclesse.unicancer.fr.; Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France. l.poulain@baclesse.unicancer.fr.; ORGAPRED core facility, US PLATON, Université de Caen Normandie, Caen, France. l.poulain@baclesse.unicancer.fr.
Publikováno v:
Experimental & molecular medicine [Exp Mol Med] 2024 Jul; Vol. 56 (7), pp. 1531-1551. Date of Electronic Publication: 2024 Jul 01.
Autor:
Larrue C; Translational Research Center for Hemato-Oncology, Faculty of Medicine, University of Geneva, Geneva, Switzerland. clement.larrue@inserm.fr.; Swiss Cancer Center Leman, Lausanne, Switzerland. clement.larrue@inserm.fr., Mouche S; Translational Research Center for Hemato-Oncology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Swiss Cancer Center Leman, Lausanne, Switzerland., Lin S; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Simonetta F; Translational Research Center for Hemato-Oncology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Swiss Cancer Center Leman, Lausanne, Switzerland., Scheidegger NK; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Poulain L; Translational Research Center for Hemato-Oncology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Swiss Cancer Center Leman, Lausanne, Switzerland., Birsen R; Translational Research Center for Hemato-Oncology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Swiss Cancer Center Leman, Lausanne, Switzerland., Sarry JE; Cancer Research Centre of Toulouse, UMR1037 Inserm, UMR5077 CNRS, Université de Toulouse 3 Paul Sabatier, Equipe Labellisée LIGUE 2018, 31037, Toulouse, France., Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Tamburini J; Translational Research Center for Hemato-Oncology, Faculty of Medicine, University of Geneva, Geneva, Switzerland. jerome.tamburinibonnefoy@unige.ch.; Swiss Cancer Center Leman, Lausanne, Switzerland. jerome.tamburinibonnefoy@unige.ch.
Publikováno v:
Leukemia [Leukemia] 2023 Apr; Vol. 37 (4), pp. 765-775. Date of Electronic Publication: 2023 Feb 04.
Autor:
Thorel L; INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), Université de Caen Normandie, Caen, France.; Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France., Divoux J; INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), Université de Caen Normandie, Caen, France.; Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France.; ORGAPRED Core Facility, US PLATON, Université de Caen Normandie, Caen, France., Lequesne J; Clinical Research Department, Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France., Babin G; INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), Université de Caen Normandie, Caen, France.; Department of Surgery, Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France., Morice PM; INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), Université de Caen Normandie, Caen, France.; Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France., Florent R; INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), Université de Caen Normandie, Caen, France.; Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France.; ORGAPRED Core Facility, US PLATON, Université de Caen Normandie, Caen, France., Desmartin G; Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France.; ORGAPRED Core Facility, US PLATON, Université de Caen Normandie, Caen, France., Lecouflet L; Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France.; ORGAPRED Core Facility, US PLATON, Université de Caen Normandie, Caen, France., Marde Alagama C; INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), Université de Caen Normandie, Caen, France., Leconte A; Clinical Research Department, Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France., Clarisse B; Clinical Research Department, Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France., Briand M; INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), Université de Caen Normandie, Caen, France.; Biological Resource Center 'OvaRessources', US PLATON, Université de Caen Normandie, Caen, France., Rouzier R; Department of Surgery, Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France., Gaichies L; Department of Surgery, Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France., Martin-Françoise S; Department of Surgery, Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France., Le Brun JF; Department of Surgery, Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France., Denoyelle C; INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), Université de Caen Normandie, Caen, France.; Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France., Vigneron N; INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), Université de Caen Normandie, Caen, France.; Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France.; Calvados General Tumor Registry, Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France., Jeanne C; Department of Pathology, Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France., Blanc-Fournier C; INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), Université de Caen Normandie, Caen, France.; Biological Resource Center 'OvaRessources', US PLATON, Université de Caen Normandie, Caen, France.; Department of Pathology, Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France., Leman R; Department of Cancer Biology and Genetics, U1245 'Cancer and Brain Genomics', Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France., Vaur D; Department of Cancer Biology and Genetics, U1245 'Cancer and Brain Genomics', Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France., Figeac M; US 41 - UAR 2014 - PLBS, University of Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, Lille, France., Meryet-Figuiere M; INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), Université de Caen Normandie, Caen, France.; Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France., Joly F; Clinical Research Department, Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France., Weiswald LB; INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), Université de Caen Normandie, Caen, France. lb.weiswald@baclesse.unicancer.fr.; Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France. lb.weiswald@baclesse.unicancer.fr.; ORGAPRED Core Facility, US PLATON, Université de Caen Normandie, Caen, France. lb.weiswald@baclesse.unicancer.fr., Poulain L; INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), Université de Caen Normandie, Caen, France. l.poulain@baclesse.unicancer.fr.; ORGAPRED Core Facility, US PLATON, Université de Caen Normandie, Caen, France. l.poulain@baclesse.unicancer.fr.; Biological Resource Center 'OvaRessources', US PLATON, Université de Caen Normandie, Caen, France. l.poulain@baclesse.unicancer.fr., Dolivet E; INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), Université de Caen Normandie, Caen, France. e.dolivet@baclesse.unicancer.fr.; Department of Surgery, Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France. e.dolivet@baclesse.unicancer.fr.
Publikováno v:
BMC cancer [BMC Cancer] 2024 Jun 07; Vol. 24 (1), pp. 701. Date of Electronic Publication: 2024 Jun 07.
Autor:
Atabakhsh, S, Poulain, L, Chen, G, Canonaco, F, Prévôt, ASH, Pöhlker, M, Wiedensohler, A, Herrmann, H
Atmospheric aerosol particles are a complex combination of primary emitted sources (biogenic and anthropogenic) and secondary aerosol resulting from aging processes such as condensation, coagulation, and cloud processing. To better understand their s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c72427456a0128439e31704a21c9c212
https://acp.copernicus.org/articles/23/6963/2023/
https://acp.copernicus.org/articles/23/6963/2023/
Autor:
Ait-Helal, W., Beeldens, A., Boonen, E., Borbon, A., Boréave, A., Cazaunau, M., Chen, H., Daële, V., Dupart, Y., Gaimoz, C., Gallus, M., George, C., Grand, N., Grosselin, B., Herrmann, H., Ifang, S., Kurtenbach, R., Maille, M., Marjanovic, I., Mellouki, A., Miet, K., Mothes, F., Poulain, L., Rabe, R., Zapf, P., Kleffmann, J., Doussin, J.-F.
Publikováno v:
In Atmospheric Environment December 2015 122:799-807